MedSentry: Adherence for complex drug regimens (podcast)

[audio src="https://healthbb.files.wordpress.com/2016/09/hbdew049-david-e-williams-interviews-medsentry-ceo-adam-wallen.mp3"][/audio]Medication adherence is a tough challenge, especially for high-risk patients, whose complex drug regimens often feature more than a dozen pills. MedSentry is rolling out an end-to-end closed loop adherence system for this population. Although it's not a large group, it is responsible for a disproportionate share of medical costs.In this podcast interview, CEO Adam Wallen and I discuss the following:

1. (0:11) Adherence is a big problem in healthcare. What does it mean? What's the nature of the problem?
2. (0:57) Are there multiple reasons for lack of adherence?
3. (4:05) There are a number of adherence solutions in the market. How well do they work?
4. (7:46) What is the MedSentry approach? How is it different?
5. (11:57) What evidence is there that this approach is effective?
6. (13:17) You have focused on the most complicated patients. Will that continue to be your niche as your commercialize?
7. (14:55) Do you have a scale-up plan?

-------By healthcare business consultant David E. Williams, president of Health Business Group.